Shots: The FDA has approved eXciteOSA to treat mild obstructive sleep apnea and snoring by using for only 20 min./day for a period of 6 wks. and then twice per […]readmore
Tags : Treating
Shots: STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With […]readmore
Shots: GSK will initiate a clinical trial to evaluate its RA drug, otilimab on patients suffering from pneumonia related to COVID-19 at the end of May’2020. The study will evaluate […]readmore
The initiation of clinical study follows the US FDA’s acceptance of IND for TJM2 (TJ003234). The study will explore the potential of TJM2 and initially be conducted in the US […]readmore
Shots: The companies collaborates on multiple projects, being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs) The focus of the collaboration […]readmore
Shots: Seattle to receive upfront plus progress-dependent milestones of up to $160M and royalties on any product sales, retaining rights for candidates in Americas (the US, Canada, and Latin American […]readmore